Mission Bio Inc. has created the first assay capable of determining measurable residual disease in cancer down to the level of individual cells.
NRG Oncology has appointed the following committee chairs and vice chairs.
Fox Chase Cancer Center and Temple Health have named the following people to the Division of Urology and Urologic Oncology.
Jordan Berlin was named interim leader of the Division of Hematology and Oncology in the Department of Medicine at Vanderbilt University Medical Center.
A $10 million gift from the Brock family, including John F. Brock III, his wife, Mary, and their three adult children—Rebecca Brock Dixon, John F. Brock IV and Major Brock—will establish the Brock Family Center for Applied Innovation at Vanderbilt University Medical Center.
OneOncology has formed five OneOncology disease groups.
Sarah Quinlan was named chief program officer of The Lymphoma Research Foundation.
Researchers who developed a camera technology inspired by the mantis shrimp’s visual system have received a $9 million P01 award from NCI.
University Hospitals Cleveland Medical Center was designated as the first SpaceOAR Hydrogel Center of Excellence in the world, led by urologic oncologist Jonathan Shoag, and radiation oncologist Daniel Spratt.
In a study published in JAMA Network Open, researchers at Yale Cancer Center assessed the acceptance of Medicaid insurance among patients diagnosed with common cancers.
